Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

Cannabis Law Report

AUGUST 19, 2021

Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. ” Despite those concerns, Joe Oliver, head of British-based cannabidiol firm LDN CBD, says his products help those with chronic illness. .

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

JANUARY 12, 2022

. “Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. ” Gb Sciences’ intellectual property portfolio includes five U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 12, 2021

The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. These dispensaries operate under strict regulations to ensure compliance with the TCUP guidelines.

Law 52

Law Clinical Trials Dispensary Programs 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. In compliance with current Good Manufacturing Practice requirements, the Company delivered ANEB-001’s active pharmaceutical ingredient to its contract manufacturer to fill into 10 mg and 50 mg capsules for finished product. June 30, 2021. .

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. Tweet this. ” Joining Ms.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. And what about conditions? I know how to collect data. Elana: Right.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

MMJ Recs

JULY 3, 2024

The prevalence of anxiety disorders and stress-related conditions has risen significantly in recent decades. For qualifying patients, staying informed about local regulations through state health department resources and reputable CBD retailers is essential to ensure compliance and safety. Image by Suzy Hazelwood on Pexels.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit. Key Responsibilities.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Today, people use CBD products to help with various medical conditions, such as diabetes, Chron’s disease, multiple sclerosis, and arthritis. With CBD, though, the “high” feeling is not created.

THC 81

THC CBD Legalization Oil 81

Cannabis Law Report

SEPTEMBER 8, 2021

EPN’s facility is capable of product development, manufacturing, and commercialization of cannabis consumer packaged goods in addition to the manufacture of products and formulations for use in clinical trials to a TGA and EU GMP standard. The conditions precedent for the execution of the Definitive Agreements are: a. .

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JULY 23, 2019

LGC and its investors will benefit from a substantial competitive advantage through their knowledge and clinical trial capacity and its capacity to handle the regulatory compliance process for pharmaceuticals and food products,” said Mazen Haddad, CEO of LGC. About LGC Capital Ltd ( www.lgc-capital.com ).

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Clinical Trials Compliance 45

Cannabis Law Report

NOVEMBER 29, 2019

Lack of clinical trials is a major reason why doctors are cautious about the drug. The Czech Republic, Italy, Malta, the Netherlands and the United Kingdom are among the other member states which have established a specific access scheme for cannabis preparations for the treatment of a narrow range of medical conditions.

Medicine 45

Medicine Clinical Trials Treatment Access 45

Cannabis Law Report

MARCH 29, 2022

With Mike, MAPS PBC is taking another major step in building a world-class pharmaceutical organization capable of meeting the enormous need for novel treatments for PTSD and other mental health conditions. I’m thrilled to expand our team with another experienced partner who shares our values. Amy Emerson , CEO, MAPS PBC. Dawn Lundin, M.S. ,

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Mental conditions like anxiety, depression, and PTSD.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

DECEMBER 7, 2021

We expect that the funding will enable the business to successfully navigate tough South African trading conditions and secure a prime spot for the business in the growing cannabis sector,” Maasdorp adds.

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

Cannabis Law Report

DECEMBER 21, 2019

Autism is a very serious health condition that affects patients’ communication and social interaction skills thus making the development and maintenance of a social relationship very difficult. Unlike most conditions, not much is known about autism. Studies conducted to validate CBD’s use for autism.

Research and Development 45

Research and Development CBD Conditions Therapy 45

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. Research has revealed that cannabinoids can be effective in managing chronic pain, alleviating symptoms of certain medical conditions, and even as an alternative treatment for mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 3, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

MARCH 1, 2022

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Manage compliance matters handled by outside counsel and consultants. Handle other compliance matters as assigned by the General Counsel.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. Yensen has admitted to having sex with Buisson after the experimental sessions ended, but while she was still enrolled in the clinical trial.

Safety 52

Safety Patients Clinical Trials Data 52

Cannabis Law Report

OCTOBER 15, 2021

Solutech™ is one of the fastest-acting, most bioavailable and comprehensively studied delivery systems for cannabinoids, including THC and CBD, uniquely differentiated for relative oral bioavailability and absorption by a Phase I human clinical trial.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

Cannabis Law Report

MARCH 21, 2019

Only CBD products produced in compliance with the Farm Bill would be legal by federal law. If you reside in any of the following 15 states, there are laws stating certain conditions must be met in order to legally obtain CBD. You can find the list of medical conditions here.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40